Insmed Q3 revenue tops $524 million; Brinsupri, Arikayce guidance raised, Japan launch underwayNov 10M&AamikacinbrensocatibUpdated
Alaunos acquires Velaris Therapeutics, lines up $350 million PIPE financingOct 13M&AAlaunos Therapeutics, Inc.Liquidia Corp
FDA grants Fast Track designation to Liquidia's YUTREPIA for SSc-related Raynaud's phenomenonSep 3Regulatory milestoneLiquidia Corptreprostinil
Liquidia reports YUTREPIA sales growth, begins enrollment in L606 pivotal studyAug 12Quarterly updateLiquidia Corptreprostinil